EQAS Therapeutic Drug Monitoring Program

EQAS Therapeutic Drug Monitoring Program

Overview

Program providing samples for 12 monthly therapeutic drug measurements at subtherapeutic, therapeutic, and toxic levels and corresponding reports for peer group result comparison via QCNet
Read full description
Ordering Information

Description

Description

  • Lyophilized, human plasma based
  • Analytes targeted at therapeutic, sub-therapeutic and toxic levels
  • 12-month cycle
  • Submit results for the appropriate sample every month
  • Weighed-in Values provided for select analytes

Analytes

  • Acetaminophen
  • Amikacin
  • Amitriptyline
  • Caffeine
  • Carbamazepine
  • Cyclosporine
  • Digoxin
  • Ethosuximide
  • Gentamicin
  • Lithium
  • Methotrexate
  
  • Nortriptyline
  • Phenobarbital
  • Phenytoin
  • Primidone
  • Salicylate
  • Theophylline
  • Tobramycin
  • Tricyclic Antidepressants (TCA) Screen
  • Valproic Acid
  • Vancomycin
 
Refer to myeinserts.com or the package insert for current analyte claims.

Ordering

Ordering

items

Use the filters below to refine results!

bc10_qsd_eqtdm_tn.jpg
(Discontinued) EQAS Therapeutic Drug Monitoring Program
BC10
External quality assurance services for 12 monthly tests of common therapeutic drugs for peer group result comparison (12 x 5 mL)

Accessories

Accessories

Documents

Documents

Number Description Options
Q-1557
EQAS Programs Brochure
[ Add to Cart (Free) ]
Q-1118
Quality Control Products & Services Catalog
[ Add to Cart (Free) ]